{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:36:58Z","timestamp":1792766218818,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.berh.2012.12.004","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T10:10:32Z","timestamp":1363428632000},"page":"33-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides"],"prefix":"10.1016","volume":"27","author":[{"given":"Jan Willem","family":"Cohen Tervaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2012.12.004_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nature Immunology"},{"key":"10.1016\/j.berh.2012.12.004_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2249.2009.03885.x","article-title":"Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis","volume":"15","author":"Tervaert","year":"2009","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.berh.2012.12.004_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00002281-199701000-00004","article-title":"Cell adhesion molecules in vasculitis","volume":"9","author":"Tervaert","year":"1997","journal-title":"Current Opinion In Rheumatology"},{"key":"10.1016\/j.berh.2012.12.004_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in\u00a0vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation","volume":"40","author":"Del Papa","year":"1997","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib5","first-page":"433","article-title":"In\u00a0vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis","volume":"17","author":"Muller Kobold","year":"1999","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"Suppl. 49","key":"10.1016\/j.berh.2012.12.004_bib6","first-page":"S135","article-title":"The role of the endothelium in systemic small vessel vasculitis","volume":"26","author":"Little","year":"2008","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2012.12.004_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0049-0172(97)80010-8","article-title":"Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies","volume":"27","author":"Belizna","year":"1997","journal-title":"Seminars In Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib8","first-page":"26","article-title":"Chemokines in vasculitis","volume":"1","author":"Eardley","year":"2009","journal-title":"Frontiers In Bioscience"},{"key":"10.1016\/j.berh.2012.12.004_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/ATVBAHA.107.154807","article-title":"Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR\u2013\/\u2013 mice","volume":"28","author":"van Leeuwen","year":"2008","journal-title":"Arteiosclerosis, Thrombosis, and Vascular Biology"},{"issue":"50 Suppl.","key":"10.1016\/j.berh.2012.12.004_bib10","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1194\/jlr.R800086-JLR200","article-title":"Myeloperoxidase, modified lipoproteins, and Atherogenesis","author":"Nicholls","year":"2009","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.berh.2012.12.004_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/tx9003775","article-title":"Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein","volume":"23","author":"Shao","year":"2010","journal-title":"Chemical Research In Toxicology"},{"key":"10.1016\/j.berh.2012.12.004_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12016-008-8094-x","article-title":"Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings","volume":"37","author":"Zinger","year":"2009","journal-title":"Clinical Reviews In Allergy & Immunology"},{"key":"10.1016\/j.berh.2012.12.004_bib13","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.101.25.2883","article-title":"Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes","volume":"101","author":"Liuzzo","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2012.12.004_bib14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.exger.2005.12.002","article-title":"Telomeres, immune aging and autoimmunity","volume":"41","author":"Goronzy","year":"2006","journal-title":"Experimental Gerontology"},{"issue":"1","key":"10.1016\/j.berh.2012.12.004_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar2923","article-title":"T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?","volume":"12","author":"Wilde","year":"2010","journal-title":"Arthritis Research & Therapy"},{"issue":"4","key":"10.1016\/j.berh.2012.12.004_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/rheumatology\/keq328","article-title":"FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells","volume":"50","author":"Abdulahad","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.berh.2012.12.004_bib17","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1186\/ar4066","article-title":". Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy","volume":"14","author":"Wilde","year":"2012","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.berh.2012.12.004_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/rheumatology\/kes345","article-title":"Metabolic syndrome in ANCA-associated vasculitis","volume":"52","author":"Petermann Smits","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2012.12.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","article-title":"European Vasculitis Study Group. EULAR recommendations for the management of large vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Annals of The Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.12.004_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/BOR.0b013e32834dc392","article-title":"Biologic treatment of large-vessel vasculitides","volume":"24","author":"Sch\u00e4fer","year":"2012","journal-title":"Current Opinion In Rheumatology"},{"key":"10.1016\/j.berh.2012.12.004_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9343(97)89458-2","article-title":"Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort","volume":"100","author":"Matteson","year":"1996","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.berh.2012.12.004_bib23","first-page":"2171","article-title":"Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality","volume":"24","author":"Gonzalez-Gay","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.12.004_bib24","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3899\/jrheum.101254","article-title":"Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study","volume":"38","author":"Ninan","year":"2011","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.12.004_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MD.0b013e3181af4518","article-title":"Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis","volume":"88","author":"Gonzalez-Gay","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2012.12.004_bib26","first-page":"74","article-title":"Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis","volume":"33","author":"Gonzalez-Juanatey","year":"2006","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.12.004_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/art.22546","article-title":"Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality?","volume":"57","author":"Gonzalez-Gay","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib28","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.23114","article-title":"Atherosclerosis in patients with biopsy-proven giant cell arteritis","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib29","first-page":"2752","article-title":"Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage","volume":"28","author":"Filer","year":"2001","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.12.004_bib30","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/ard.2005.047498","article-title":"Atherosclerosis in Takayasu arteritis","volume":"65","author":"Seyahi","year":"2006","journal-title":"Annals of The Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.12.004_bib31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(00)02701-X","article-title":"Takayasu's arteritis","volume":"356","author":"Numano","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2012.12.004_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/03009740252937595","article-title":"Carotid and femoral artery stiffness in Takayasu's arteritis. An Ultrasound Study","volume":"31","author":"Raninen","year":"2002","journal-title":"Scand Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.12.004_bib33","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1253\/circj.CJ-09-0839","article-title":"Assessment of mechanical properties of common carotid artery in Takayasu's arteritis using velocity vector imaging","volume":"74","author":"Cho","year":"2010","journal-title":"Circulation Journal"},{"key":"10.1016\/j.berh.2012.12.004_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3988\/jcn.2012.8.2.109","article-title":"Ischemic stroke in Takayasu's arteritis: lesion patterns and possible mechanisms","volume":"8","author":"Hwang","year":"2012","journal-title":"Journal of Clinical Neurology"},{"key":"10.1016\/j.berh.2012.12.004_bib35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.autrev.2007.04.001","article-title":"Coronary involvement in Takayasu's arteritis","volume":"6","author":"Rav-Acha","year":"2007","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.berh.2012.12.004_bib36","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jcmg.2011.04.019","article-title":"Coronary CT angiography in Takayasu arteritis","volume":"4","author":"Soto","year":"2011","journal-title":"JACC Cardiovascular Imaging"},{"key":"10.1016\/j.berh.2012.12.004_bib37","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/01.CIR.94.9.2103","article-title":"Endothelial dysfunction late after Kawasaki disease","volume":"94","author":"Dhillon","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2012.12.004_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpeds.2007.03.056","article-title":"Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?","volume":"151","author":"McCrindle","year":"2007","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.berh.2012.12.004_bib39","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1542\/peds.107.5.1095","article-title":"Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions","volume":"107","author":"Noto","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.berh.2012.12.004_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/adc.2006.096628","article-title":"Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease","volume":"92","author":"Cheung","year":"2007","journal-title":"Archives of Disease In Childhood"},{"key":"10.1016\/j.berh.2012.12.004_bib41","doi-asserted-by":"crossref","first-page":"e38998","DOI":"10.1371\/journal.pone.0038998","article-title":"Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study","volume":"7","author":"Orenstein","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2012.12.004_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2012.01.049","article-title":"Characteristics of earlier atherosclerotic involvement in adolescent patients with Kawasaki disease and coronary artery lesions: significance of gray scale median on B-mode ultrasound","volume":"222","author":"Noto","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.berh.2012.12.004_bib43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ki.2010.472","article-title":"New pathophysiological insights and treatment of ANCA-associated vasculitis","volume":"79","author":"Wilde","year":"2011","journal-title":"Kidney International"},{"key":"10.1016\/j.berh.2012.12.004_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12016-012-8320-4","article-title":"Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?","volume":"43","author":"Cohen Tervaert","year":"2012","journal-title":"Clinical Reviews In Allergy & Immunology"},{"key":"10.1016\/j.berh.2012.12.004_bib45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/rheumatology\/keq351","article-title":"Mortality in Wegener's granulomatosis: a bimodal pattern","volume":"50","author":"Luqmani","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2012.12.004_bib46","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/ard.2010.145250","article-title":"European Vasculitis Study Group (EUVAS). Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials","volume":"70","author":"Heijl","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.12.004_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/acr.20433","article-title":"A model to predict cardiovascular events in patients with newly diagnosed wegener's granulomatosis and microscopic polyangiitis","author":"Suppiah","year":"2011","journal-title":"Arthritis Care and Research (Hoboken)"},{"key":"10.1016\/j.berh.2012.12.004_bib48","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.24386","article-title":"Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis","volume":"60","author":"Faurschou","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib49","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/art.24957","article-title":"Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study","volume":"60","author":"Morgan","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib50","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/01.CIR.102.13.1470","article-title":"Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?","volume":"102","author":"Raza","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2012.12.004_bib51","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.0000124720.18538.DD","article-title":"Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation","volume":"109","author":"Booth","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2012.12.004_bib52","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/030097497199712063049","article-title":"Enhanced endothelium-dependent vasodilator responses in patients with systemic vasculitis","volume":"26","author":"Bruce","year":"1997","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.12.004_bib53","first-page":"1875","article-title":"Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis","volume":"34","author":"Nienhuis","year":"2007","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.12.004_bib54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.20002","article-title":"Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation","volume":"50","author":"Booth","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib55","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/rheumatology\/ken155","article-title":". Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis","volume":"47","author":"Sangle","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2012.12.004_bib56","series-title":"Inflammatory diseases of blood vessels","first-page":"475","article-title":"Cholesterol and modifications of cholesterol in rheumatic disorders","author":"Cohen Tervaert","year":"2012"},{"key":"10.1016\/j.berh.2012.12.004_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMe1012520","article-title":"HDL and cardiovascular-disease risk-time for a new approach?","volume":"364","author":"Heinecke","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2012.12.004_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar2471","article-title":"Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis","volume":"10","author":"Hahn","year":"2008","journal-title":"Arthritis Research & Therapy"},{"key":"10.1016\/j.berh.2012.12.004_bib59","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and athersclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.berh.2012.12.004_bib60","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2012.12.004_bib61","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semarthrit.2007.03.002","article-title":"PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis","volume":"37","author":"Qu\u00e9m\u00e9neur","year":"2007","journal-title":"Seminars In Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib63","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1253\/circj.CJ-08-0582","article-title":"Altered flow-mediated vasodilatation, low paraoxonase-1 activity, and abnormal high-density lipoprotein subclass distribution in Takayasu's arteritis","volume":"73","author":"Espinola-Zavaleta","year":"2009","journal-title":"Circulation Journal"},{"key":"10.1016\/j.berh.2012.12.004_bib64","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1185\/030079907X226104","article-title":"Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol","volume":"23","author":"Bergheanu","year":"2007","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.berh.2012.12.004_bib65","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0889-8529(05)70033-5","article-title":"Drugs causing dyslipoproteinemia","volume":"27","author":"Donahoo","year":"1998","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.berh.2012.12.004_bib66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","article-title":"Risk factors for coronary artery disease in patients with systemic lupus erythematosus","volume":"93","author":"Petri","year":"1992","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.berh.2012.12.004_bib67","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.semarthrit.2008.01.015","article-title":"Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment","volume":"38","author":"Steiner","year":"2009","journal-title":"Seminars In Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib68","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/ard.2006.059691","article-title":"Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis","volume":"66","author":"Peters","year":"2007","journal-title":"Annals of The Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.12.004_bib69","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/acr.20393","article-title":"Hydroxychloroquine use is associated with improvement in lipid profiles in rheumatoid arthritis patients","volume":"63","author":"Morris","year":"2010","journal-title":"Arthritis Care and Research"},{"key":"10.1016\/j.berh.2012.12.004_bib70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00041552-200205000-00004","article-title":"Role of oxidized low-density lipoprotein in renal disease","volume":"11","author":"Heeringa","year":"2002","journal-title":"Current Opinion In Nephrology and Hypertension"},{"key":"10.1016\/j.berh.2012.12.004_bib71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.autrev.2009.03.001","article-title":"The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis","volume":"9","author":"Van Leeuwen","year":"2009","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.berh.2012.12.004_bib72","first-page":"821","article-title":"Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease","volume":"55","author":"Gounopoulos","year":"2007","journal-title":"Minerva Biotecnol"},{"key":"10.1016\/j.berh.2012.12.004_bib73","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2249.2007.03420.x","article-title":"Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins","volume":"149","author":"Slot","year":"2007","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.berh.2012.12.004_bib74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2009.08.013","article-title":"Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease","volume":"134","author":"Frostegard","year":"2010","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.berh.2012.12.004_bib75","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib76","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.22141","article-title":"Antiplatelet and anticoagulant therapy in patients with giant cell arteritis","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib77","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1253\/circj.CJ-09-0905","article-title":"Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis","volume":"74","author":"de Souza","year":"2010","journal-title":"Circulation Journal"},{"key":"10.1016\/j.berh.2012.12.004_bib78","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/rheumatology\/ken465","article-title":"Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis","volume":"48","author":"Salvarani","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2012.12.004_bib79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/rheumatology\/ken480","article-title":"High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition","volume":"48","author":"Berger","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2012.12.004_bib80","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.amjmed.2010.03.024","article-title":"Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events","volume":"123","author":"Rubenfire","year":"2010","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.berh.2012.12.004_bib81","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/11319380-000000000-00000","article-title":"Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment","volume":"33","author":"Chatzizisis","year":"2010","journal-title":"Drug Safety"},{"key":"10.1016\/j.berh.2012.12.004_bib82","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2011.06.002","article-title":"Association between statin use and lupus-like syndrome using spontaneous reports","volume":"41","author":"de Jong","year":"2011","journal-title":"Seminars In Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.12.004_bib83","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.2011.155622","article-title":"Use of statins is associated with an increased risk of rheumatoid arthritis","volume":"71","author":"de Jong","year":"2012","journal-title":"Annals of The Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.12.004_bib84","doi-asserted-by":"crossref","first-page":"e41289","DOI":"10.1371\/journal.pone.0041289","article-title":"Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case\/non-case approach","volume":"7","author":"de Jong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2012.12.004_bib85","doi-asserted-by":"crossref","first-page":"e1000336","DOI":"10.1371\/journal.pmed.1000336","article-title":"Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study","volume":"7","author":"Chodick","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.berh.2012.12.004_bib86","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar3814","article-title":"Statins accelerate the onset of collagen type II-induced arthritis in mice","volume":"14","author":"Vandebriel","year":"2012","journal-title":"Arthritis Research & Therapy"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694213000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T02:04:04Z","timestamp":1562810644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694213000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1521694213000028"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2012.12.004","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2012.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}